Current visiting times

After suspending visiting earlier in the year, we are now able to offer limited visiting to some wards at the discretion of the nurse in-charge.”

Read more on visiting times...


Messages for loved ones and keeping in touch

We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication.  Our ward staff are keeping in touch with patients’ next of kin directly and our Patient Advice and Liaison Service (PALS) can help pass on personal messages from family and friends.

Read more information about messages for loved ones…

Current visiting times

After suspending visiting earlier in the year, we are now able to offer limited visiting to some wards at the discretion of the nurse in-charge.”

Read more on visiting times...


Messages for loved ones and keeping in touch

We recognise the impact that a long stay in hospital can have on families and the importance of maintaining strong communication.  Our ward staff are keeping in touch with patients’ next of kin directly and our Patient Advice and Liaison Service (PALS) can help pass on personal messages from family and friends.

Read more information about messages for loved ones…

During your stay in hospital you will meet a number of different members of staff.  All members of staff wear name badges, but if you are not sure who someone is or what they do, please feel free to ask them to introduce themselves and explain what they do. 

If you have any questions about your treatment, please ask a doctor or a nurse.

There are lots of opportunities for you to get involved with the Trust, from volunteering to attending our public meetings, our Annual General Meeting or our hospital open day which is held every year.

Research

Last updated: 05 December 2019

The Diabetes Department has had a long record of research projects collaborating locally, nationally and internationally to work on new approaches to manage diabetes. We have worked on a variety of projects ranging from large multi-centre trials looking at new oral and injectable therapies, trials involving the use of blood glucose monitoring equipment, in particular, the Freestyle Libre looking at flash glucose monitoring and simple questionnaire studies.

We have our own in-house projects run by research fellows. One of which has been the DOVE (Dysglycaemic  Oxidative Stress and the Vascular Endothelium ) project run by Professor Mike Cummings in collaboration with Dr David Laight, Senior Lecturer at Portsmouth University. To date we have had eight research fellows examining the links between these novel risk markers of vascular disease in particular looking at the therapeutic benefits of aspirin, folic acid,nitrates, grapeseed extract, vitamin D and garlic.

Professor Mike Cummings - Consultant lead for research in diabetes


Sharon Allard - Senior Research Nurse

Since coming into the post as a Research Nurse in 1989, Sharon has been responsible for the Management of Clinical Research projects within the Department of Diabetes and Endocrinology for Portsmouth Hospitals NHS Trust, including coordinating the management of several concurrent research projects, commercial and in-house projects.

As a Senior Research Nurse, Sharon leads a team of Research Nurses and Research Fellows and provides support and development opportunities to Research nurses within the Trust. She is currently the Principal Investigator for one of the department’s home grown studies.

Over the course of her career, Sharon has had the opportunity to see the field of Diabetes Research grow and develop. She and her team have participated in many exciting research projects and look forward to future therapies for people with diabetes.Sharon's role enables her to develop a holistic relationship with her patients, which allows her to incorporate patient teaching and education to help them manage their diabetes more effectively.

Christine Hall - Research Nurse

Chris joined the research team in 2017.She is the lead nurse for the Quality of Life Study and supports the other research nurses within the team. Chris is also a Diabetes Specialist Midwife and supports clinical trials that involve pregnancy in diabetes.


Vikki Hunter - Research Nurse

Vikki joined the research team in 2013.She is the lead research nurse for the Start Right and Trimaster study. She is involved in the day to day running of all the clinical trials within the department, which includes identifying, screening and recruiting eligible participants.


Sophie Daltry - Research Nurse

Sophie joined the research team in 2013 to compliment her Diabetes Specialist Nurse role. She is the lead research nurse for the Address 2 study and shares the workload with the other research nurses.

Dr Kate Millar - Research Fellow

Kate joined the research team in 2018 to work on her own project the Drive perioperative study. She assists the research nurses with the medical aspects of their studies.

PORTFOLIO STUDIES

START RIGHT

Getting the right classification and treatment from diagnosis of Diabetes This is a 3 year study for patients diagnosed with diabetes within the last 12 months and requiring insulin therapy from diagnosis. Aged 30+.

The effect of injectable therapies on health status, quality of life and treatment satisfaction in patients with type 2 diabetes: prospective observational cohort study Patients with Type 2 diabetes treated with diet or oral medications only who are planning to start a new oral diabetes medication or injectable diabetes treatments to improve their diabetes control.

ADDRESS 2

This is a database for patients newly diagnosed with Type 1 diabetes (recruited within the first six months of diagnosis). Once on the database, they can be contacted about future diabetes research projects, many looking at halting the progression of the disease or preventing it. Collection of information and blood samples is required to understand more about the development and progression of Type 1 diabetes.

TRIMASTER

Randomised double-blind crossover study of a DPP4 inhibitor, SGLT2inhibitor and Thiazolidinedione as third line therapy in patients with type 2 diabetes who have suboptimal control on dual therapy with metformin and a sulphonylurea or metformin alone. A research study to help improve treatment of type 2 diabetes, by learning how individuals respond to different blood sugar-lowering therapies.

DRIVE PERI-OPERATIVE STUDY

To explore the association between pre-operative indicators of glycaemic control and perioperative glycaemia associated risk in patients with type 2 diabetes undergoing elective orthopaedic surgery using continuous glucose monitoring.

COMMERCIAL STUDIES

SURPASS 2

Study Randomised, open-label trial comparing the safety and efficacy of a new glucagon-like peptide-1 receptor (GLP-1 ) versus a marketed GLP-1 once weekly as add on therapy to Metformin in patients with Type 2 diabetes.

There are many exciting projects on the horizon awaiting set up.

Back to top
Working together to drive excellence in care for our patients and communities Page feedback Tell us what you think

Get in touch

Queen Alexandra Hospital,
Cosham,
Portsmouth,
PO6 3LY

© 2021, Portsmouth Hospitals NHS Trust